A new antibiotic complex of six aureolic acids was isolated from the marine sediment-associated strain Streptomyces sp. KMM 9048. Four of the compounds (3-6) were found to be similar but not identical to the known chromomycins A 2 , A 3 , demethyl chromomycin A 3 and A 4 . The two remaining compounds, A 2-1 (1) and A 3-1 (2), were established as novel chromomycin analogs, which did not contain sugar B. Spectroscopic methods including 1D and 2D NMR, and HRMS and MS/MS were applied for structure elucidation. Compounds 1-5 showed strong antimicrobial activity against Gram-positive indicatory bacteria Enterococcus faecium, Staphylococcus aureus, S. epidermidis, and Bacillus subtilis. Antitumor assay indicated that all tested compounds, in different manners, inhibited colony formation of RPMI-7951 and SK-Mel-28 cancer cells. This is the first study reporting the inhibitory effects of chromomycin analogs 1-5 on the colony formation of the investigated cancer cell lines. Compound 3, in a concentration of 5 nM, inhibited colony formation of RPMI-7951 and SK-Mel-28 cells by 82 % and 72 %, respectively. Our finding indicated that, of the compounds tested, 3 and 4 are promising anticancer and antimicrobial agents.
Microorganisms from marine habitats are a rich source of structurally unique natural compounds with a broad spectrum of biological activities, including antibacterial and anticancer [1, 2] . Streptomyces strains are one of the most investigated actinobacteria from which a lot of bioactive natural products have been obtained [3] [4] [5] . During the screening of microorganisms isolated from marine sediments for antimicrobial activity Streptomyces-like strains having antimicrobial effect were found. Among them, strain Streptomyces sp. KMM 9048 was determined to possess significant inhibitory activity against Gram-positive and Gram-negative indicatory bacteria and it was selected for further study of its bioactive metabolites.
A new antibiotics complex was isolated from the culture broth of Streptomyces sp. KMM 9048. The active fraction with an UV profile λ max 230, 283, 315 and 420 nm and IR absorption bands at 3420 and 1730 cm -1 was determined to be a mixture of at least six components (1) (2) (3) (4) (5) (6) which exhibited properties characteristic of the aureolic acids group. Aureolic acids represent a family of antitumor antibiotics [6, 7] that include mithramycin [8, 9] , olivomycins A and B, chromomycins A 2 and A 3 [10] [11] [12] , UCH9 [13, 14] , and durhamycin A [15] . These compounds are glycosylated aromatic polyketides containing a tricyclic aglycone with an aliphatic side chain attached at C-3. In some cases a small alkyl residue (methyl, isobutyl) is attached at position C-7. In all members of the family, two O-glycoside linked saccharide chains are bound to the aromatic polyketide moiety. In the case of mithramycin, chromomycins, and olivomycins, these chains contain two and three deoxysugars. UCH9 and durhamycin contain a tetrasaccharide and a mono-or disaccharide, respectively. The sugars belong to the 2, 6dideoxysugar family and comprise different combinations of Dolivose, D-oliose, D-mycarose, L-chromose B, and O-methylated or O-acetylated derivatives. Most of the aureolic acid antibiotics are produced by terrestrial Streptomycetes, but in recent years a few strain-producers were found from marine sources [16] [17] [18] [19] . Some of these antibiotics have been used in the treatment of tumor diseases [7, 20] . Since the application of aureolic acids is limited due to their side effects [21] the search for novel active analogs and their modifications is of importance [16, [22] [23] [24] [25] . The four isolated compounds 3-6 were found to be similar, but not identical to known chromomycins A 2 , A 3 , demethyl chromomycin A 3 and A 4 [10] [11] [12] [26] [27] [28] . Two other compounds A 2-1 (1) and A 3-1 (2) were determined as novel chromomycin analogs, present in trace amounts. Figure 1 ) of the two aromatic singlets at δ 6.87 (H-5) and δ 6.90 (H-10) to carbons C-6, C-7, C-8a, C-10 and C-5, C-8a, C-9a, C-10a, respectively, indicated the positioning of the aromatic protons in a peri-relationship on a naphthalene core. The HMBC correlations from the aromatic proton H-10 to C-4, from H-4 to C-4a and from the methine proton H-1 ' to C-4, C-3, and C-2 determined the structure of the aglycone with a side chain at position 3 of the aglycone. In addition C-2 is connected to C-1, as judged from the 2 J C-H correlation H-2/C-1. The key HMBC correlations from H-1 ' (δ Н 4.75) and H-3 ' (δ Н 3.99) to C-2 ' (δ С 211), from H-3 ' to C-4 ' and C-5 ' , and from H-1 ' to 1 ' -OCH 3 allowed the establishment of a unique dihydroxy-methoxy-oxo-pentyl segment of the side-chain. The methyl group C-11 is connected to C-7 of the polyaromatic moiety, as judged from the H-11 (δ 2.09) to C-6, C-7, and C-8 HMBC correlations. The proton and carbon spectral assignments of the sugar moieties were made possible by a combination of COSY, TOCSY, HSQC, and HMBC experiments.
Antibiotic complex of six aureolic acids Natural Product Communications Vol. 12 (4) 2017 573
The five anomeric protons (δ 4.71-5.41) in the 1 H NMR spectrum and the corresponding 13 C signals (δ 92.3-100.2) in the 13 C NMR spectrum revealed the presence of five sugars ( Table 1) . The 1 H-1 H connectivities of the sugars were determined by COSY and TOCSY experiments, which indicated that they are all 2,6-dideoxy sugars. This provided an opportunity for the five sugars to be linked in two groups as disaccharide and trisaccharide moieties. The linkages between the sugars were deduced by the HMBC correlation from the anomeric proton of one sugar to the carbon of the neighboring sugar at the position of linkage and vice versa ( 
NOEs between H-3 of the preceding sugar and H-1 of the following sugar were observed for the trisaccharide moieties. In this way comparison of the 1 H and 13 C NMR spectra of 3 with those of chromomycin A 2 showed their considerable structural similarity [12] . Table 2 ). Comparison of the spectral data with that published [11, 12] showed that 4 was similar to chromomycin A 3 .
The molecular formula of compound 1 was determined as Table 2 ). It means that the fragment associated with the disaccharide chain remained unaltered. The presence of another fragmentary ion at m/z 497 arising from cleavage at C-2 and sequentially the loss of the E unit from the end of the chain (m/z 283) confirmed that the isobutyryl group is located on the outer sugar of the trisaccharide unit and is identical to that for 3 ( Table 2 ). ion at m/z 469, arising from cleavage at C-2, and sequentially the loss of the E unit from the end of the chain (m/z 283) confirmed that the acetyl group is located at the end of the sugar of the trisaccharide unit and is identical to that of 4 ( 26 , which is 14 amu smaller than that found for 4. We have assumed that compound 5 has a structure identical to that of 4, but without one methoxy group. The known chromomycins A 2 and A 3 had two methoxy groups, one of which belongs to the aglycone and the other to the B unit outer sugar of the disaccharide moiety. A preliminary analysis based on MS showed that compounds 1-6 isolated from Streptomyces sp. was established as the 4E-deacetyl analog of 4. The monodeacetyl derivative of A 3 (called A 4 ) was previously produced by either alkaline hydrolysis of A 3 or by biotransformation of A 2 and isolated from a marine-derived Streptomyces sp. [11, 29, 16] .
Measurement of the optical rotations for isolated chromomycins 1-5 showed positive values. The results obtained were contrary to the majority of the described chromomycins family [8, [10] [11] [12] 26] , which have negative values, excepting monodeacetylchromomycin A 3 [16] , 02-3D and 02-3G [30] and chromomycin A 5 [31] . The compounds 02-3D and 02-3G were the A-sugar deacetyl derivative of chromomycin A 3 and dideacetyl chromomycin A 3 , respectively. Chromomycin A 5 , as reported, was a stereoisomer of chromomycin A 2 at C-2 and/or C-3, but its absolute stereochemistry has not been determined [31] . It can be explained by epimerization occurring either during isolation procedures or biosynthesis due to the presence of several chiral centers in the side chain of the aglycone of aureolic acids derivatives. Comparison of 13 C signals of carbon atoms C-2, C-3, C-4 and C-1 ' , C-3 ' and C-4 ' for 3 and 4 with those for A 2 , A 3 and A 5 showed their similarity, except for signal C- Compounds 1-5 showed strong antimicrobial activity against the Gram-positive indicatory bacteria E. faecium, S. aureus, S. epidermidis, and B. subtilis (Table 3 ). Compounds 3, 4 and 5 were mostly active against B. subtilis, and 3 and 4 against B. subtilis and E. faecium; compounds 1 and 2 were less active. We used compounds 1-5 to test their cytotoxic effects on SK-Mel-28 and RPMI-7951 cells using the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay. No cytotoxicity was observed in any of the tested cells in concentrations from 1.25 to 10 μM, but these compounds slightly inhibited cell proliferation of SK-Mel-28 and RPMI-7951 cells after 48 and 72 h. Cytotoxicity was determined for chromomycin A 2 against colon adenocarcinoma (HCT-116), promyelocytic leukemia HL-60, metastatic melanoma MALME-3M, ovarian adenocarcinoma (OVCAR-8), metastatic prostate carcinoma (PC-3M), glioblastoma (SF-295), and lung fibroblast (MRC-5) cells [19] .
Chromomycin A 2 showed cytotoxicity against the investigated cell lines in nM concentrations only after 48 and 72 h, and after 24 h the cytotoxicity was more than 400 nM. Melanoma cells MALME-3M have been reported to be more sensitive to chromomycin A 2 . This compound, at 30 nM, increased accumulation of cells in the G0/G1 phase, while chromomycin A 3 at 30 nM presented no effect in this process [19] . The inhibitory rate of chromomycin A 3 against P388 mouse leukemia cells, BEL-7402 human liver cancer cells and A-549 human lung cancer cells was up to 81.6%, 92.3%, and 100%, respectively, at a concentration of 10 -8 mol/L [32] .
Antibiotic complex of six aureolic acids Natural Product Communications Vol. 12 (4) 2017 575 It was found that 3 almost completely reduced the colony number of both cell lines compared with control cells (Figure 2 ). Compound 3, at a concentration of 5 nM, inhibited colony formation of RPMI-7951 and SK-Mel-28 by 82 and 72%, respectively. So, the IC 50 for RPMI-7951 cells was 3.1 nM and for SK-Mel-28 3.6 nM. Compound 1 was 10 fold less active than 3: IC 50 for RPMI-7951 cells was 32.8 nM and for SK-Mel-28 38.3 nM ( Table 4 ). The ability of compound 4 to inhibit colony formation of melanoma cells was low compared with 3, but it was more active than 2. For comparison, cisplatin at 3 µM inhibited colony formation of RPMI-7951 and SK-Mel-28 melanoma cells less than 45%. In general, our finding indicated that compound 3 inhibited colony formation of cancer cells and is a promising anticancer agent. Streptomyces sp. KMM 9048 were incubated in 1 L flasks, each containing 0.5 L of the above mentioned medium for 12 d at 25°C with shaking (120 rpm); a total of 10 L of culture was obtained.
Extraction and isolation:
The cells were removed via filtration and extracted twice with ethyl acetate. The filtrate was extracted twice with an equal volume of ethyl acetate, and the combined ethyl acetate extracts from cells and filtrate were washed with H 2 O, dried over Na 2 SO 4 and evaporated to a small volume (10 mL). The concentrate was diluted with n-hexane to precipitate yellow pigments, which were filtered off, washed with n-hexane and dried in vacuum to give 415 mg of yellow powder. The crude antibiotic complex was fractionated by Sephadex LH-20 column chromatography (CC) with a chloroform-methanol (1:1) mixture. As a result, 9 fractions were obtained. The active yellow fractions 3-7 were combined and the solvent evaporated under reduced pressure to obtain 220 mg of yellow powder. This was dissolved in 1.0 mL of chloroform and applied to a column packed with silica gel. By gradient elution with chloroform containing increasing amount of methanol (100:0→9:1), 30 fractions were collected and assayed for antibacterial activities. Fractions 14-25 were active and enriched in aureolic acid-containing metabolites, as indicated by LC-MS. Fractions 14-23 were combined and the solvent was evaporated under reduced pressure. This active fraction was further subjected to reversed-phase HPLC on a YMC-Pack-ODS-A column (250 x 4.6 mm I.D, 5 μm, 12 nm) to gave active chromomycins 1 (t R 12.9 min, 1.7 mg), 2 (t R 7.6 min, 1.5 mg), 3 (t R 14.9 min, 17.1 mg), 4 (t R 8.5 min, 15.7 mg) and 5 (t R 6.6 min, 1.8 mg). The system was operated at a flow rate of 0.8 mL/min with a solvent mixture of 47% acetonitrile and 53% H 2 O, detection by UV absorption at 279 nm. The combined fraction 24-25 was further purified by preparative silica gel TLC with a chloroform/methanol/H 2 O solvent system (85/15/1, v/v) to obtain chromomycin 6 (R f 0.32, 1.5 mg).
Antimicrobial assay:
The inhibitory activity against indicatory microorganisms, Escherichia coli K-12 CL588, Enterococcus faecium CIP 104105, Staphylococcus aureus CIP 65.8 T , S. epidermidis CIP 81.55 T , Bacillus subtilis CIP 52.65 T , Xanthomonas sp. pv. badrii LMG 546, and Candida albicans KMM 455, obtained from the respective Culture Collections, was tested by an agar diffusion method, as described previously [33] .
Materials:
The medium DMEM, fetal bovine serum (FBS), Lglutamine, and gentamicin were purchased from Biolot (Russia). CellTiter 96 nonradioactive cell proliferation assay kits were purchased from Promega (Madison, WI).
Cell culture:
The SK-Mel-28 (ATCC # HTB-72) and RPMI-7951 (ATCC # HTB-66) human malignant melanoma cell lines were grown in monolayers in DMEM, supplemented with 10% (v/v) heat-inactivated FBS, 2 mM L-glutamine, and 1% penicillinstreptomycin in a humidified atmosphere containing 5% CO 2 .
Cell proliferation assay:
To estimate cell cytotoxicity, SK-Mel-28 and RPMI-7951 (3x10 4 ) cells were seeded in 96-well plates in 200 μL of 10% FBS MEM and McCoy, respectively, at 37C in a 5% CO 2 incubator. After 24 h, the medium was removed and serial 1-5 dilutions of three 2-fold dilution steps covering the range from 10 to 1.25 μM in fresh medium were prepared and replaced for an additional 24 h at 37C in a 5% CO 2 incubator. After incubation, 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4sulfophenyl)-2H-tetrazolium, inner salt (MTS reagent) (10 μL) was added to each well, and cells were then incubated for 4 h at 37C in 5% CO 2 . Absorbance was measured at 490/630 nm.
